'Significant Milestone' for Radionuclide Therapy in Refractory Meningioma

Published Date: 04 Oct 2024

Small study suggests large benefit for Lu-177 dotatate in intracranial disease

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Kansas Cancer Center awarded two Indian American doctors professorships.

2.

Key mechanism behind prostate cancer drug resistance reveals potential new treatment strategy

3.

The lack of psychiatrists may be addressed by community workers.

4.

Living near St. Louis-area Coldwater Creek during childhood linked with higher risk of cancer from radiation

5.

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot